Marburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses

Spencer W. Stonier, Andrew S. Herbert, Ana I. Kuehne, Ariel Sobarzo, Polina Habibulin, Chen V.Abramovitch Dahan, Rebekah M. James, Moses Egesa, Stephen Cose, Julius Julian Lutwama, Leslie Lobel, John M. Dye

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Until recently, immune responses in filovirus survivors remained poorly understood. Early studies revealed IgM and IgG responses to infection with various filoviruses, but recent outbreaks have greatly expanded our understanding of filovirus immune responses. Immune responses in survivors of Ebola virus (EBOV) and Sudan virus (SUDV) infections have provided the most insight, with T cell responses as well as detailed antibody responses having been characterized. Immune responses to Marburg virus (MARV), however, remain almost entirely uncharacterized. We report that immune responses in MARV survivors share characteristics with EBOV and SUDV infections but have some distinct differences. MARV survivors developed multivariate CD4+ T cell responses but limited CD8+ T cell responses, more in keeping with SUDV survivors than EBOV survivors. In stark contrast to SUDV survivors, rare neutralizing antibody responses in MARV survivors diminished rapidly after the outbreak. These results warrant serious consideration for any vaccine or therapeutic that seeks to be broadly protective, as different filoviruses may require different immune responses to achieve immunity.

Original languageEnglish
Pages (from-to)2563-2572
Number of pages10
JournalJournal of Experimental Medicine
Issue number9
StatePublished - 1 Jan 2017

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Marburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses'. Together they form a unique fingerprint.

Cite this